Cargando…

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder

Current pharmacological treatments for bipolar disorder (BD) are limited and efficacy has historically been discovered through serendipity. There is now scope for new drug development, focused on the underlying biology of BD that is not targeted by current therapies. The need for novel treatments is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodd, Seetal, Fernandes, Brisa S., Dean, Olivia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761635/ https://www.ncbi.nlm.nih.gov/pubmed/26467413 http://dx.doi.org/10.2174/1570159X13666150630175841

Ejemplares similares

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012)

Tobacco Use in Bipolar Disorder
por: Thomson, Daniel, et al.
Publicado: (2015)

Evaluation of pharmacotherapy in inpatients with mania in bipolar disorder
por: Piróg-Balcerzak, Agnieszka, et al.
Publicado: (2010)

Staging in bipolar disorder: one step closer to precision psychiatry
por: Fernandes, Brisa S., et al.
Publicado: (2017)

Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression?
por: Russell, Samantha E., et al.
Publicado: (2023)

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder
por: Berk, Lesley, et al.
Publicado: (2013)

Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2011)

Treatment-resistant bipolar depression: concepts and challenges for novel interventions
por: Diaz, Alexandre P., et al.
Publicado: (2021)

Obesity Pharmacotherapy: Current Perspectives and Future Directions
por: Misra, Monika
Publicado: (2013)

Precision pharmacotherapy: psychiatry’s future direction in preventing, diagnosing, and treating mental disorders
por: Menke, Andreas
Publicado: (2018)

ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression
por: Nordenskjöld, Axel
Publicado: (2015)

Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an Update
por: Muneer, Ather
Publicado: (2015)

Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents
por: Cox, Joanna H., et al.
Publicado: (2014)

Shared decision making in pharmacotherapy decisions, perceived by patients with bipolar disorder
por: Verwijmeren, Doris, et al.
Publicado: (2018)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions
por: Elsayed, Omar H, et al.
Publicado: (2022)

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
por: Ashton, Melanie M., et al.
Publicado: (2019)

Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
por: Russell, Samantha E., et al.
Publicado: (2022)

Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric Disorders
por: Dodd, Seetal, et al.
Publicado: (2022)

Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder
por: Kim, Sung-Wan, et al.
Publicado: (2015)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

Genetic contributions to bipolar disorder: current status and future directions
por: O'Connell, Kevin S., et al.
Publicado: (2021)

Functional Remediation for Bipolar Disorder
por: Martínez-Arán, Anabel, et al.
Publicado: (2011)

Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study
por: Del Casale, Antonio, et al.
Publicado: (2022)

Pharmacotherapy for treatment-resistant schizophrenia
por: Mcilwain, Meghan E, et al.
Publicado: (2011)

Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study
por: Gliddon, Emma, et al.
Publicado: (2015)

The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research
por: Goldstein, Benjamin I, et al.
Publicado: (2017)

Pharmacotherapy of Acute Bipolar Depression in Adults: An Evidence Based Approach
por: Muneer, Ather
Publicado: (2016)

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice
por: Kulkarni, Jayashri, et al.
Publicado: (2012)

Pharmacotherapy treatment of stimulant use disorder
por: Liu, Mei T.
Publicado: (2021)

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
por: Pompili, Maurizio, et al.
Publicado: (2008)

Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
por: Sharma, Anjalee, et al.
Publicado: (2016)

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Inam, Mehmet Enes, et al.
Publicado: (2023)

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial
por: Arancini, Lauren, et al.
Publicado: (2019)

Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015)

Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service
por: Paterniti, Sabrina, et al.
Publicado: (2013)

Pharmacotherapies for Diabetic Retinopathy: Present and Future
por: Schwartz, Stephen G., et al.
Publicado: (2007)

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
por: Solé, Brisa, et al.
Publicado: (2017)

Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_e6nchoctrla22bja3se5ui53d6